Lars Lannfeldt

Top news31 Jul

Medicine Stop a Hard Blow for Alzheimer's Patients

The disappointment is great since a new drug against Alzheimer's has been rejected by the EU's pharmaceutical authority. It is outrageous, says Liselotte Jansson at the Alzheimer's Foundation.

Sweden

26 Jul

Alzheimer's drug rejected by EMA

The Alzheimer's drug lecanemab has not been approved by the European Medicines Agency EMA. The benefits are not considered to outweigh the potential drawbacks. A review of the decision will be requested, announces Swedish Bioarctic – whose share plummeted on the news.

Sweden

You're up to date in Lars Lannfeldt

That's every story in Lars Lannfeldt for now.